Answers are grounded in this paper and cite their sources.
We identified a group of platelet protein biomarker candidates that can quantify the differential expression between ovarian cancer cases as compared to benign adnexal lesions.
No takes yet. Share an insight, caveat, or question.
Lomnytska et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: